Digital drawing test shows promise in detecting early-stage dementia
By
Aaron Dorman
Feb 28, 2024
A drawing test that involves sketching a clock was able to better identify early dementia than paper-and-pencil alternatives, research shows.
Higher pancreatic fat percentage linked to lower cognition in men
Feb 27, 2024
Higher pancreatic fat was linked to lower cognition and brain volumes in middle-aged men at high risk for Alzheimer’s disease.
When it comes to dementia care, words matter, experts say
By
Kimberly Bonvissuto
Feb 27, 2024
Words matter, especially in the field of dementia care, according to a panel of experts who debated the effects of language used in the senior living industry, particularly surrounding memory care.
We need to do better for people living with dementia
By
Rob Liebreich
Feb 26, 2024
With 97% of income for those with dementia going to care costs, we need to do better. Senior living and care should be the No. 1 force for change.
Aegis Living, SLR recognized for achieving elevated memory care standards
By
Kimberly Bonvissuto
Feb 26, 2024
Two assisted living and memory care providers have earned certifications for meeting elevated standards of care for people living with dementia.
Digital assistive tech vital to dignity among dementia patients: report
By
Aaron Dorman
Feb 23, 2024
A recent review of studies around “digital assistive tech” showed those tools helped people living with dementia preserve dignity and monitor health.
Timing of CSF biomarker divergence for Alzheimer’s disease, normal cognition varies
Feb 21, 2024
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.
State updates plan to improve access to dementia care
By
Kimberly Bonvissuto
Feb 21, 2024
Rhode Island recently unveiled a five-year update to its state plan to improve access to dementia care as well as improve quality of life for those living with Alzheimer’s disease or another form of...
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Bill calls for $165 million in funding for Alzheimer’s-related initiatives
By
Kimberly Bonvissuto
Feb 12, 2024
Bipartisan bills recently introduced in the US Senate and House of Representatives, if passed as written and signed into law, would fund public health initiatives related to Alzheimer’s disease to the...